

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.44735011 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.44735011 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.18759030 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.18759030 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.65562983 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.47040015 |
| 7 | glyoxylate metabolic process (GO:0046487) | 6.21425028 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.92440601 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.92440601 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.92440601 |
| 11 | high-density lipoprotein particle remodeling (GO:0034375) | 5.80829239 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.80342154 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.62604388 |
| 14 | negative regulation of fibrinolysis (GO:0051918) | 5.60942560 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.57455276 |
| 16 | cysteine metabolic process (GO:0006534) | 5.46066826 |
| 17 | regulation of fibrinolysis (GO:0051917) | 5.34808761 |
| 18 | behavioral response to nicotine (GO:0035095) | 5.33974138 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.33711015 |
| 20 | urea cycle (GO:0000050) | 5.32934320 |
| 21 | urea metabolic process (GO:0019627) | 5.32934320 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 5.25202289 |
| 23 | reverse cholesterol transport (GO:0043691) | 5.22644756 |
| 24 | serine family amino acid catabolic process (GO:0009071) | 5.17588472 |
| 25 | lysine metabolic process (GO:0006553) | 5.17573403 |
| 26 | lysine catabolic process (GO:0006554) | 5.17573403 |
| 27 | protein carboxylation (GO:0018214) | 5.14141503 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.14141503 |
| 29 | regulation of cholesterol esterification (GO:0010872) | 5.06007743 |
| 30 | oxidative demethylation (GO:0070989) | 4.99239928 |
| 31 | plasma lipoprotein particle remodeling (GO:0034369) | 4.97205655 |
| 32 | protein-lipid complex remodeling (GO:0034368) | 4.97205655 |
| 33 | macromolecular complex remodeling (GO:0034367) | 4.97205655 |
| 34 | nitrogen cycle metabolic process (GO:0071941) | 4.91071624 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.88157680 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.86689397 |
| 37 | regulation of protein activation cascade (GO:2000257) | 4.86425755 |
| 38 | homocysteine metabolic process (GO:0050667) | 4.85014784 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 4.82523727 |
| 40 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.79478372 |
| 41 | phospholipid efflux (GO:0033700) | 4.76136162 |
| 42 | bile acid metabolic process (GO:0008206) | 4.75382933 |
| 43 | cellular ketone body metabolic process (GO:0046950) | 4.71495385 |
| 44 | amino-acid betaine metabolic process (GO:0006577) | 4.70770936 |
| 45 | complement activation, alternative pathway (GO:0006957) | 4.68765895 |
| 46 | negative regulation of cholesterol transport (GO:0032375) | 4.66960558 |
| 47 | negative regulation of sterol transport (GO:0032372) | 4.66960558 |
| 48 | tyrosine metabolic process (GO:0006570) | 4.65091735 |
| 49 | plasma lipoprotein particle clearance (GO:0034381) | 4.64486473 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.61337556 |
| 51 | acylglycerol homeostasis (GO:0055090) | 4.58503633 |
| 52 | triglyceride homeostasis (GO:0070328) | 4.58503633 |
| 53 | epoxygenase P450 pathway (GO:0019373) | 4.52713168 |
| 54 | regulation of complement activation (GO:0030449) | 4.49276101 |
| 55 | drug catabolic process (GO:0042737) | 4.34252033 |
| 56 | cholesterol efflux (GO:0033344) | 4.34176206 |
| 57 | omega-hydroxylase P450 pathway (GO:0097267) | 4.33846406 |
| 58 | glycine metabolic process (GO:0006544) | 4.32241944 |
| 59 | glutamate metabolic process (GO:0006536) | 4.31524604 |
| 60 | serine family amino acid metabolic process (GO:0009069) | 4.31321059 |
| 61 | cellular amino acid catabolic process (GO:0009063) | 4.30170852 |
| 62 | plasma lipoprotein particle assembly (GO:0034377) | 4.25486132 |
| 63 | cellular modified amino acid catabolic process (GO:0042219) | 4.23118364 |
| 64 | indolalkylamine metabolic process (GO:0006586) | 4.22219552 |
| 65 | nucleobase catabolic process (GO:0046113) | 4.15763283 |
| 66 | serine family amino acid biosynthetic process (GO:0009070) | 4.15521789 |
| 67 | aldehyde catabolic process (GO:0046185) | 4.14034602 |
| 68 | amine catabolic process (GO:0009310) | 4.08456829 |
| 69 | cellular biogenic amine catabolic process (GO:0042402) | 4.08456829 |
| 70 | ketone body metabolic process (GO:1902224) | 4.07905391 |
| 71 | urate metabolic process (GO:0046415) | 4.03914021 |
| 72 | benzene-containing compound metabolic process (GO:0042537) | 4.02093568 |
| 73 | short-chain fatty acid metabolic process (GO:0046459) | 4.01736055 |
| 74 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.00495950 |
| 75 | coenzyme catabolic process (GO:0009109) | 3.98742710 |
| 76 | drug transmembrane transport (GO:0006855) | 3.96778053 |
| 77 | bile acid and bile salt transport (GO:0015721) | 3.96315038 |
| 78 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.95111404 |
| 79 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.95111404 |
| 80 | fibrinolysis (GO:0042730) | 3.93406898 |
| 81 | arginine metabolic process (GO:0006525) | 3.93212139 |
| 82 | low-density lipoprotein particle remodeling (GO:0034374) | 3.93006819 |
| 83 | cellular glucuronidation (GO:0052695) | 3.92920423 |
| 84 | imidazole-containing compound metabolic process (GO:0052803) | 3.91137934 |
| 85 | ethanol oxidation (GO:0006069) | 3.88609621 |
| 86 | phospholipid homeostasis (GO:0055091) | 3.84986371 |
| 87 | aspartate family amino acid catabolic process (GO:0009068) | 3.84521602 |
| 88 | protein-lipid complex assembly (GO:0065005) | 3.83371224 |
| 89 | organic acid catabolic process (GO:0016054) | 3.79895682 |
| 90 | carboxylic acid catabolic process (GO:0046395) | 3.79895682 |
| 91 | cholesterol homeostasis (GO:0042632) | 3.79497755 |
| 92 | blood coagulation, intrinsic pathway (GO:0007597) | 3.79116797 |
| 93 | plasma lipoprotein particle organization (GO:0071827) | 3.78857241 |
| 94 | drug metabolic process (GO:0017144) | 3.75456367 |
| 95 | sterol homeostasis (GO:0055092) | 3.75213033 |
| 96 | positive regulation of lipid catabolic process (GO:0050996) | 3.75130167 |
| 97 | acetyl-CoA metabolic process (GO:0006084) | 3.71236465 |
| 98 | lipoprotein metabolic process (GO:0042157) | 3.68760120 |
| 99 | negative regulation of lipase activity (GO:0060192) | 3.68581073 |
| 100 | 2-oxoglutarate metabolic process (GO:0006103) | 3.63353904 |
| 101 | regulation of plasminogen activation (GO:0010755) | 3.63081164 |
| 102 | exogenous drug catabolic process (GO:0042738) | 3.61998593 |
| 103 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.58911801 |
| 104 | protein-lipid complex subunit organization (GO:0071825) | 3.57411739 |
| 105 | glucuronate metabolic process (GO:0019585) | 3.56148758 |
| 106 | uronic acid metabolic process (GO:0006063) | 3.56148758 |
| 107 | cofactor catabolic process (GO:0051187) | 3.56000440 |
| 108 | alkaloid metabolic process (GO:0009820) | 3.53009374 |
| 109 | response to pheromone (GO:0019236) | 3.47858952 |
| 110 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.44949132 |
| 111 | phenylpropanoid metabolic process (GO:0009698) | 3.44207089 |
| 112 | S-adenosylmethionine metabolic process (GO:0046500) | 3.42487122 |
| 113 | gamma-aminobutyric acid transport (GO:0015812) | 3.34553417 |
| 114 | indole-containing compound metabolic process (GO:0042430) | 3.29340703 |
| 115 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.19698110 |
| 116 | detection of light stimulus involved in visual perception (GO:0050908) | 3.19698110 |
| 117 | flavonoid metabolic process (GO:0009812) | 3.10574544 |
| 118 | neural tube formation (GO:0001841) | 3.04524346 |
| 119 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.95970091 |
| 120 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.94847538 |
| 121 | epithelial cilium movement (GO:0003351) | 2.92686460 |
| 122 | arginine catabolic process (GO:0006527) | 2.91958743 |
| 123 | dopamine transport (GO:0015872) | 2.88079719 |
| 124 | tachykinin receptor signaling pathway (GO:0007217) | 2.86520509 |
| 125 | behavioral response to ethanol (GO:0048149) | 2.83719186 |
| 126 | heme transport (GO:0015886) | 2.81245234 |
| 127 | amino acid salvage (GO:0043102) | 2.79393801 |
| 128 | L-methionine salvage (GO:0071267) | 2.79393801 |
| 129 | L-methionine biosynthetic process (GO:0071265) | 2.79393801 |
| 130 | synaptic transmission, cholinergic (GO:0007271) | 2.77193000 |
| 131 | iron coordination entity transport (GO:1901678) | 2.75101969 |
| 132 | L-fucose metabolic process (GO:0042354) | 2.74814926 |
| 133 | L-fucose catabolic process (GO:0042355) | 2.74814926 |
| 134 | fucose catabolic process (GO:0019317) | 2.74814926 |
| 135 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.66921053 |
| 136 | sulfation (GO:0051923) | 2.66821433 |
| 137 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.65826997 |
| 138 | positive regulation of fatty acid transport (GO:2000193) | 2.65507140 |
| 139 | establishment of protein localization to Golgi (GO:0072600) | 2.60604268 |
| 140 | nonmotile primary cilium assembly (GO:0035058) | 2.57639163 |
| 141 | photoreceptor cell maintenance (GO:0045494) | 2.56749339 |
| 142 | disruption of cells of other organism (GO:0044364) | 2.55966688 |
| 143 | killing of cells of other organism (GO:0031640) | 2.55966688 |
| 144 | somite development (GO:0061053) | 2.54045060 |
| 145 | sodium-independent organic anion transport (GO:0043252) | 2.53496528 |
| 146 | peptidyl-glutamic acid modification (GO:0018200) | 2.49880268 |
| 147 | NAD biosynthetic process (GO:0009435) | 2.49703088 |
| 148 | cilium movement (GO:0003341) | 2.48848417 |
| 149 | parturition (GO:0007567) | 2.48734489 |
| 150 | axoneme assembly (GO:0035082) | 2.47971033 |
| 151 | negative regulation of astrocyte differentiation (GO:0048712) | 2.45139504 |
| 152 | reflex (GO:0060004) | 2.44665933 |
| 153 | ethanol metabolic process (GO:0006067) | 2.44130523 |
| 154 | positive regulation of icosanoid secretion (GO:0032305) | 2.43734221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.32077974 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.14748815 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.72464640 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.41542251 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.05754881 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.05688898 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.98634858 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.33544077 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.92118861 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.86505649 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.25727635 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 3.03311277 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.94710719 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.71978135 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.54786385 |
| 16 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.46979121 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.45121781 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.34317768 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.29385099 |
| 20 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.17932021 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.12211300 |
| 22 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.11496630 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09913033 |
| 24 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08099550 |
| 25 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8854997 |
| 26 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.92501463 |
| 27 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.87554072 |
| 28 | FUS_26573619_Chip-Seq_HEK293_Human | 1.82716973 |
| 29 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.81691187 |
| 30 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.72788150 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.72682653 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.71217605 |
| 33 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.70834122 |
| 34 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.68270790 |
| 35 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.67471643 |
| 36 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.66948978 |
| 37 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62891365 |
| 38 | EWS_26573619_Chip-Seq_HEK293_Human | 1.61597909 |
| 39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.60441171 |
| 40 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.60107556 |
| 41 | STAT3_23295773_ChIP-Seq_U87_Human | 1.59869068 |
| 42 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.58917319 |
| 43 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.58604745 |
| 44 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.57343342 |
| 45 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.57040370 |
| 46 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.56856871 |
| 47 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.56856871 |
| 48 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.52887354 |
| 49 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.49808412 |
| 50 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.49666328 |
| 51 | TCF4_23295773_ChIP-Seq_U87_Human | 1.47826450 |
| 52 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.46921004 |
| 53 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.46217287 |
| 54 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.46217287 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46137596 |
| 56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.43662738 |
| 57 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.42979032 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39445541 |
| 59 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.38524241 |
| 60 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.38405696 |
| 61 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.37576500 |
| 62 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37095355 |
| 63 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36489289 |
| 64 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35267789 |
| 65 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.35260362 |
| 66 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.34855723 |
| 67 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.33107260 |
| 68 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.32718291 |
| 69 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.32330880 |
| 70 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.30006267 |
| 71 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.29992739 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28539788 |
| 73 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.27725986 |
| 74 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.26770130 |
| 75 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.26770130 |
| 76 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26148260 |
| 77 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.25064721 |
| 78 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.22570068 |
| 79 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.22497602 |
| 80 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.22364426 |
| 81 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21984245 |
| 82 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.21575731 |
| 83 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.20725532 |
| 84 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.18653177 |
| 85 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.18643469 |
| 86 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.18470541 |
| 87 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.18021633 |
| 88 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.17389037 |
| 89 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16227943 |
| 90 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.15955017 |
| 91 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.15498162 |
| 92 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.15368502 |
| 93 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.14749063 |
| 94 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.13813217 |
| 95 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12937176 |
| 96 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12819391 |
| 97 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12210983 |
| 98 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.12181770 |
| 99 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.11997674 |
| 100 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.10438803 |
| 101 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.09899604 |
| 102 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09858130 |
| 103 | NCOR_22424771_ChIP-Seq_293T_Human | 1.09350101 |
| 104 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.09258336 |
| 105 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.06844792 |
| 106 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.06781579 |
| 107 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.06718135 |
| 108 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.06667941 |
| 109 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.05845352 |
| 110 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05428983 |
| 111 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.05298730 |
| 112 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.03843105 |
| 113 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03632311 |
| 114 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.03512884 |
| 115 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.03379830 |
| 116 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.03379830 |
| 117 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.03319077 |
| 118 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.02650797 |
| 119 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.02406165 |
| 120 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.00839085 |
| 121 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00372576 |
| 122 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.99418426 |
| 123 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99347541 |
| 124 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.99216322 |
| 125 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.96243223 |
| 126 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.93051593 |
| 127 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87465432 |
| 128 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81877830 |
| 129 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.78944510 |
| 130 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78918680 |
| 131 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.78629248 |
| 132 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78400927 |
| 133 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.78290011 |
| 134 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78062731 |
| 135 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77717144 |
| 136 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.77620743 |
| 137 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.75910759 |
| 138 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74744751 |
| 139 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.74215628 |
| 140 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72435238 |
| 141 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72303897 |
| 142 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.72204310 |
| 143 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71668053 |
| 144 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.71640230 |
| 145 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.68806605 |
| 146 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68511364 |
| 147 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.68358194 |
| 148 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.68052550 |
| 149 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67729209 |
| 150 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66956852 |
| 151 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.66826214 |
| 152 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.59968396 |
| 153 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.59653994 |
| 154 | GATA1_19941826_ChIP-Seq_K562_Human | 0.57247006 |
| 155 | AR_20517297_ChIP-Seq_VCAP_Human | 0.56479802 |
| 156 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.56157581 |
| 157 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.56157581 |
| 158 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55652026 |
| 159 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.55154776 |
| 160 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.54528699 |
| 161 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53265489 |
| 162 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.52886321 |
| 163 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52513439 |
| 164 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.50473260 |
| 165 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.49997299 |
| 166 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.49385190 |
| 167 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49247869 |
| 168 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.49158710 |
| 169 | GATA2_19941826_ChIP-Seq_K562_Human | 0.49153146 |
| 170 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.48776656 |
| 171 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.48557857 |
| 172 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.48129042 |
| 173 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.45942614 |
| 174 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45882537 |
| 175 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.45401578 |
| 176 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.44998791 |
| 177 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44802035 |
| 178 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.44071372 |
| 179 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.43269283 |
| 180 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42967241 |
| 181 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42091893 |
| 182 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.41893045 |
| 183 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.41260248 |
| 184 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.41171176 |
| 185 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.40327790 |
| 186 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39061283 |
| 187 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.38749186 |
| 188 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.38417745 |
| 189 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.38414550 |
| 190 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.37329973 |
| 191 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.37189416 |
| 192 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37189324 |
| 193 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.37129649 |
| 194 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.37072224 |
| 195 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.36586731 |
| 196 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.36380737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.05128509 |
| 2 | MP0005360_urolithiasis | 7.90744025 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.01044893 |
| 4 | MP0005365_abnormal_bile_salt | 5.89339298 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.95570332 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.02113844 |
| 7 | MP0003252_abnormal_bile_duct | 3.74837576 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.54724331 |
| 9 | MP0009840_abnormal_foam_cell | 3.33015372 |
| 10 | MP0005332_abnormal_amino_acid | 3.16126577 |
| 11 | MP0003195_calcinosis | 3.15423431 |
| 12 | MP0003787_abnormal_imprinting | 2.85917797 |
| 13 | MP0005083_abnormal_biliary_tract | 2.83516265 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.74061354 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.56470755 |
| 16 | MP0006292_abnormal_olfactory_placode | 2.52967327 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.48711401 |
| 18 | MP0000569_abnormal_digit_pigmentation | 2.32268504 |
| 19 | MP0005551_abnormal_eye_electrophysiolog | 2.27936820 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.18688769 |
| 21 | MP0008877_abnormal_DNA_methylation | 2.16727962 |
| 22 | MP0000609_abnormal_liver_physiology | 2.08281727 |
| 23 | MP0001986_abnormal_taste_sensitivity | 2.05850410 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 2.05349564 |
| 25 | MP0004142_abnormal_muscle_tone | 1.99693566 |
| 26 | MP0006276_abnormal_autonomic_nervous | 1.98524374 |
| 27 | MP0003646_muscle_fatigue | 1.97438416 |
| 28 | MP0005646_abnormal_pituitary_gland | 1.89942857 |
| 29 | MP0001968_abnormal_touch/_nociception | 1.85734849 |
| 30 | MP0005319_abnormal_enzyme/_coenzyme | 1.81973696 |
| 31 | MP0009745_abnormal_behavioral_response | 1.79660278 |
| 32 | MP0002102_abnormal_ear_morphology | 1.78192866 |
| 33 | MP0001764_abnormal_homeostasis | 1.74959846 |
| 34 | MP0002163_abnormal_gland_morphology | 1.71785107 |
| 35 | MP0009643_abnormal_urine_homeostasis | 1.69469541 |
| 36 | MP0003868_abnormal_feces_composition | 1.69165714 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.65804570 |
| 38 | MP0002272_abnormal_nervous_system | 1.65057894 |
| 39 | MP0003880_abnormal_central_pattern | 1.63739300 |
| 40 | MP0002736_abnormal_nociception_after | 1.61166982 |
| 41 | MP0005451_abnormal_body_composition | 1.59731445 |
| 42 | MP0005423_abnormal_somatic_nervous | 1.59080340 |
| 43 | MP0003136_yellow_coat_color | 1.56997172 |
| 44 | MP0009046_muscle_twitch | 1.56247708 |
| 45 | MP0002638_abnormal_pupillary_reflex | 1.48320489 |
| 46 | MP0009697_abnormal_copulation | 1.46814425 |
| 47 | MP0006072_abnormal_retinal_apoptosis | 1.45546089 |
| 48 | MP0001486_abnormal_startle_reflex | 1.43199978 |
| 49 | MP0003186_abnormal_redox_activity | 1.41645382 |
| 50 | MP0005645_abnormal_hypothalamus_physiol | 1.39036954 |
| 51 | MP0003011_delayed_dark_adaptation | 1.37760456 |
| 52 | MP0005379_endocrine/exocrine_gland_phen | 1.37006149 |
| 53 | MP0005253_abnormal_eye_physiology | 1.36340037 |
| 54 | MP0001984_abnormal_olfaction | 1.34147169 |
| 55 | MP0003121_genomic_imprinting | 1.33590632 |
| 56 | MP0004885_abnormal_endolymph | 1.33295637 |
| 57 | MP0005636_abnormal_mineral_homeostasis | 1.31975486 |
| 58 | MP0004145_abnormal_muscle_electrophysio | 1.28818434 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.28394102 |
| 60 | MP0002572_abnormal_emotion/affect_behav | 1.27061133 |
| 61 | MP0001485_abnormal_pinna_reflex | 1.25734876 |
| 62 | MP0003122_maternal_imprinting | 1.23914053 |
| 63 | MP0000778_abnormal_nervous_system | 1.23673226 |
| 64 | MP0003878_abnormal_ear_physiology | 1.23477574 |
| 65 | MP0005377_hearing/vestibular/ear_phenot | 1.23477574 |
| 66 | MP0003635_abnormal_synaptic_transmissio | 1.23062926 |
| 67 | MP0001440_abnormal_grooming_behavior | 1.20138954 |
| 68 | MP0002064_seizures | 1.18793117 |
| 69 | MP0000631_abnormal_neuroendocrine_gland | 1.17810499 |
| 70 | MP0000372_irregular_coat_pigmentation | 1.17288505 |
| 71 | MP0000598_abnormal_liver_morphology | 1.16425065 |
| 72 | MP0002653_abnormal_ependyma_morphology | 1.14878189 |
| 73 | MP0002557_abnormal_social/conspecific_i | 1.14645598 |
| 74 | MP0000427_abnormal_hair_cycle | 1.13769957 |
| 75 | MP0000604_amyloidosis | 1.12991269 |
| 76 | MP0002063_abnormal_learning/memory/cond | 1.12511055 |
| 77 | MP0001970_abnormal_pain_threshold | 1.11254226 |
| 78 | MP0010386_abnormal_urinary_bladder | 1.10902245 |
| 79 | MP0005195_abnormal_posterior_eye | 1.10601478 |
| 80 | MP0001501_abnormal_sleep_pattern | 1.10593904 |
| 81 | MP0002733_abnormal_thermal_nociception | 1.10247834 |
| 82 | MP0003879_abnormal_hair_cell | 1.08098739 |
| 83 | MP0004133_heterotaxia | 1.07631849 |
| 84 | MP0004742_abnormal_vestibular_system | 1.07102533 |
| 85 | MP0005174_abnormal_tail_pigmentation | 1.05381218 |
| 86 | MP0002067_abnormal_sensory_capabilities | 1.05061635 |
| 87 | MP0009764_decreased_sensitivity_to | 1.04461598 |
| 88 | MP0003705_abnormal_hypodermis_morpholog | 1.02961885 |
| 89 | MP0001756_abnormal_urination | 1.02417861 |
| 90 | MP0004924_abnormal_behavior | 1.00638776 |
| 91 | MP0005386_behavior/neurological_phenoty | 1.00638776 |
| 92 | MP0001905_abnormal_dopamine_level | 1.00407592 |
| 93 | MP0010368_abnormal_lymphatic_system | 1.00319033 |
| 94 | MP0004043_abnormal_pH_regulation | 0.98275771 |
| 95 | MP0005647_abnormal_sex_gland | 0.96077877 |
| 96 | MP0002752_abnormal_somatic_nervous | 0.94955330 |
| 97 | MP0002735_abnormal_chemical_nociception | 0.94784796 |
| 98 | MP0006036_abnormal_mitochondrial_physio | 0.94729157 |
| 99 | MP0003890_abnormal_embryonic-extraembry | 0.94528032 |
| 100 | MP0002254_reproductive_system_inflammat | 0.92806135 |
| 101 | MP0009763_increased_sensitivity_to | 0.92671396 |
| 102 | MP0002234_abnormal_pharynx_morphology | 0.92643083 |
| 103 | MP0009642_abnormal_blood_homeostasis | 0.92111737 |
| 104 | MP0005084_abnormal_gallbladder_morpholo | 0.92022912 |
| 105 | MP0005408_hypopigmentation | 0.90786307 |
| 106 | MP0002184_abnormal_innervation | 0.90599160 |
| 107 | MP0002160_abnormal_reproductive_system | 0.89474154 |
| 108 | MP0008469_abnormal_protein_level | 0.88633901 |
| 109 | MP0001529_abnormal_vocalization | 0.87579962 |
| 110 | MP0002229_neurodegeneration | 0.85827614 |
| 111 | MP0000955_abnormal_spinal_cord | 0.85291091 |
| 112 | MP0002938_white_spotting | 0.84973298 |
| 113 | MP0008789_abnormal_olfactory_epithelium | 0.83810833 |
| 114 | MP0002876_abnormal_thyroid_physiology | 0.83701633 |
| 115 | MP0005389_reproductive_system_phenotype | 0.83320581 |
| 116 | MP0000026_abnormal_inner_ear | 0.82952080 |
| 117 | MP0002136_abnormal_kidney_physiology | 0.82943735 |
| 118 | MP0001293_anophthalmia | 0.81195900 |
| 119 | MP0005376_homeostasis/metabolism_phenot | 0.80641103 |
| 120 | MP0002909_abnormal_adrenal_gland | 0.79605869 |
| 121 | MP0002078_abnormal_glucose_homeostasis | 0.79577767 |
| 122 | MP0001963_abnormal_hearing_physiology | 0.79440560 |
| 123 | MP0005670_abnormal_white_adipose | 0.74403785 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.73351862 |
| 125 | MP0005535_abnormal_body_temperature | 0.72885657 |
| 126 | MP0005220_abnormal_exocrine_pancreas | 0.72675941 |
| 127 | MP0003329_amyloid_beta_deposits | 0.67243233 |
| 128 | MP0009053_abnormal_anal_canal | 0.66103969 |
| 129 | MP0001661_extended_life_span | 0.65548809 |
| 130 | MP0002971_abnormal_brown_adipose | 0.64932318 |
| 131 | MP0001765_abnormal_ion_homeostasis | 0.63401722 |
| 132 | MP0005334_abnormal_fat_pad | 0.60189623 |
| 133 | MP0005266_abnormal_metabolism | 0.59295566 |
| 134 | MP0003690_abnormal_glial_cell | 0.58335702 |
| 135 | MP0004130_abnormal_muscle_cell | 0.58055026 |
| 136 | MP0000639_abnormal_adrenal_gland | 0.56501114 |
| 137 | MP0006035_abnormal_mitochondrial_morpho | 0.54179378 |
| 138 | MP0005395_other_phenotype | 0.54066092 |
| 139 | MP0003638_abnormal_response/metabolism_ | 0.53165663 |
| 140 | MP0005464_abnormal_platelet_physiology | 0.51051953 |
| 141 | MP0004264_abnormal_extraembryonic_tissu | 0.50998560 |
| 142 | MP0005058_abnormal_lysosome_morphology | 0.50611673 |
| 143 | MP0002928_abnormal_bile_duct | 0.48814726 |
| 144 | MP0005448_abnormal_energy_balance | 0.46353511 |
| 145 | MP0000230_abnormal_systemic_arterial | 0.44207125 |
| 146 | MP0003075_altered_response_to | 0.43838883 |
| 147 | MP0003718_maternal_effect | 0.43720916 |
| 148 | MP0003953_abnormal_hormone_level | 0.43648972 |
| 149 | MP0005666_abnormal_adipose_tissue | 0.42516354 |
| 150 | MP0009672_abnormal_birth_weight | 0.41867852 |
| 151 | MP0008872_abnormal_physiological_respon | 0.41023141 |
| 152 | MP0002168_other_aberrant_phenotype | 0.40812963 |
| 153 | MP0008873_increased_physiological_sensi | 0.40725587 |
| 154 | MP0008874_decreased_physiological_sensi | 0.40679578 |
| 155 | MP0002796_impaired_skin_barrier | 0.40036176 |
| 156 | MP0002135_abnormal_kidney_morphology | 0.37680201 |
| 157 | MP0002837_dystrophic_cardiac_calcinosis | 0.37521587 |
| 158 | MP0005166_decreased_susceptibility_to | 0.37069766 |
| 159 | MP0004883_abnormal_blood_vessel | 0.35525041 |
| 160 | MP0004782_abnormal_surfactant_physiolog | 0.35174768 |
| 161 | MP0004147_increased_porphyrin_level | 0.34884348 |
| 162 | MP0003724_increased_susceptibility_to | 0.34586157 |
| 163 | MP0002822_catalepsy | 0.33927991 |
| 164 | MP0000538_abnormal_urinary_bladder | 0.32667246 |
| 165 | MP0003436_decreased_susceptibility_to | 0.31114766 |
| 166 | MP0005167_abnormal_blood-brain_barrier | 0.30037464 |
| 167 | MP0000249_abnormal_blood_vessel | 0.29972511 |
| 168 | MP0001845_abnormal_inflammatory_respons | 0.29570776 |
| 169 | MP0009115_abnormal_fat_cell | 0.29295137 |
| 170 | MP0001243_abnormal_dermal_layer | 0.27590797 |
| 171 | MP0005164_abnormal_response_to | 0.26663772 |
| 172 | MP0006082_CNS_inflammation | 0.26120625 |
| 173 | MP0005248_abnormal_Harderian_gland | 0.24807494 |
| 174 | MP0002970_abnormal_white_adipose | 0.23750307 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.07834476 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.98788938 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.52956781 |
| 4 | Xanthomatosis (HP:0000991) | 6.13612600 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.06082298 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.01560474 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.86996961 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.03189994 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.71072801 |
| 10 | Joint hemorrhage (HP:0005261) | 4.67270442 |
| 11 | Hyperammonemia (HP:0001987) | 4.64689068 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.57366093 |
| 13 | Hyperglycinuria (HP:0003108) | 4.51415388 |
| 14 | Complement deficiency (HP:0004431) | 4.48765120 |
| 15 | Ketosis (HP:0001946) | 4.46103799 |
| 16 | Hyperglycinemia (HP:0002154) | 4.44199459 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.33297238 |
| 18 | Abnormality of glycine metabolism (HP:0010895) | 4.33297238 |
| 19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.26044187 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.20216147 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 4.19353720 |
| 22 | Pancreatic fibrosis (HP:0100732) | 4.14723091 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.13875940 |
| 24 | Pancreatic cysts (HP:0001737) | 4.13036672 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 4.11136173 |
| 26 | Hypoglycemic coma (HP:0001325) | 3.99008710 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.92947529 |
| 28 | Epidermoid cyst (HP:0200040) | 3.92675361 |
| 29 | Fat malabsorption (HP:0002630) | 3.69160138 |
| 30 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.64267497 |
| 31 | Molar tooth sign on MRI (HP:0002419) | 3.64167748 |
| 32 | Abnormality of midbrain morphology (HP:0002418) | 3.64167748 |
| 33 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.59787916 |
| 34 | True hermaphroditism (HP:0010459) | 3.55039505 |
| 35 | Gout (HP:0001997) | 3.52948161 |
| 36 | Congenital stationary night blindness (HP:0007642) | 3.52743956 |
| 37 | Progressive cerebellar ataxia (HP:0002073) | 3.51858624 |
| 38 | Abnormality of the intrinsic pathway (HP:0010989) | 3.51514094 |
| 39 | Ketoacidosis (HP:0001993) | 3.38939142 |
| 40 | Medial flaring of the eyebrow (HP:0010747) | 3.34758759 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 3.32114265 |
| 42 | Hypercholesterolemia (HP:0003124) | 3.28038122 |
| 43 | Nephronophthisis (HP:0000090) | 3.25599410 |
| 44 | Abnormality of complement system (HP:0005339) | 3.23868091 |
| 45 | Hyperbilirubinemia (HP:0002904) | 3.21207719 |
| 46 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.19601393 |
| 47 | Conjugated hyperbilirubinemia (HP:0002908) | 3.19313440 |
| 48 | Abnormality of purine metabolism (HP:0004352) | 3.18277440 |
| 49 | Delayed CNS myelination (HP:0002188) | 3.15252711 |
| 50 | Abnormality of serum amino acid levels (HP:0003112) | 3.08344903 |
| 51 | Hepatocellular carcinoma (HP:0001402) | 3.02970206 |
| 52 | Abnormality of the renal cortex (HP:0011035) | 3.01490135 |
| 53 | Metabolic acidosis (HP:0001942) | 2.95505435 |
| 54 | Chronic hepatic failure (HP:0100626) | 2.93980738 |
| 55 | Genetic anticipation (HP:0003743) | 2.91078048 |
| 56 | Hyperventilation (HP:0002883) | 2.90430370 |
| 57 | Abnormality of the renal medulla (HP:0100957) | 2.89762784 |
| 58 | Gait imbalance (HP:0002141) | 2.85854143 |
| 59 | Spontaneous abortion (HP:0005268) | 2.84144649 |
| 60 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.83790585 |
| 61 | Dicarboxylic aciduria (HP:0003215) | 2.83790585 |
| 62 | Cystic liver disease (HP:0006706) | 2.75738762 |
| 63 | Abolished electroretinogram (ERG) (HP:0000550) | 2.73570652 |
| 64 | Lethargy (HP:0001254) | 2.73259874 |
| 65 | Generalized aminoaciduria (HP:0002909) | 2.71013394 |
| 66 | Vascular calcification (HP:0004934) | 2.70553918 |
| 67 | Steatorrhea (HP:0002570) | 2.70465740 |
| 68 | Hypochromic microcytic anemia (HP:0004840) | 2.69063543 |
| 69 | Proximal tubulopathy (HP:0000114) | 2.67853254 |
| 70 | Congenital primary aphakia (HP:0007707) | 2.67265534 |
| 71 | Alkalosis (HP:0001948) | 2.65229088 |
| 72 | Fair hair (HP:0002286) | 2.57963371 |
| 73 | Attenuation of retinal blood vessels (HP:0007843) | 2.57148942 |
| 74 | Febrile seizures (HP:0002373) | 2.56410428 |
| 75 | Type II lissencephaly (HP:0007260) | 2.53390156 |
| 76 | Abnormal biliary tract physiology (HP:0012439) | 2.50733051 |
| 77 | Bile duct proliferation (HP:0001408) | 2.50733051 |
| 78 | Myocardial infarction (HP:0001658) | 2.50173956 |
| 79 | Increased purine levels (HP:0004368) | 2.48703281 |
| 80 | Hyperuricemia (HP:0002149) | 2.48703281 |
| 81 | Hypoglycemic seizures (HP:0002173) | 2.47934032 |
| 82 | Cerebral edema (HP:0002181) | 2.47460468 |
| 83 | Nephrogenic diabetes insipidus (HP:0009806) | 2.46366212 |
| 84 | Enlarged kidneys (HP:0000105) | 2.45987960 |
| 85 | Malnutrition (HP:0004395) | 2.44903238 |
| 86 | Spastic diplegia (HP:0001264) | 2.44380231 |
| 87 | Irritability (HP:0000737) | 2.44172261 |
| 88 | Systemic lupus erythematosus (HP:0002725) | 2.44054387 |
| 89 | Acanthocytosis (HP:0001927) | 2.43831056 |
| 90 | Pendular nystagmus (HP:0012043) | 2.43628123 |
| 91 | Neonatal onset (HP:0003623) | 2.40659151 |
| 92 | Cardiovascular calcification (HP:0011915) | 2.39886074 |
| 93 | Skin nodule (HP:0200036) | 2.39113501 |
| 94 | Renal cortical cysts (HP:0000803) | 2.36203360 |
| 95 | Decreased central vision (HP:0007663) | 2.35874103 |
| 96 | Hydroxyprolinuria (HP:0003080) | 2.35142051 |
| 97 | Abnormality of proline metabolism (HP:0010907) | 2.35142051 |
| 98 | Vomiting (HP:0002013) | 2.34344933 |
| 99 | Protruding tongue (HP:0010808) | 2.33902991 |
| 100 | Amyloidosis (HP:0011034) | 2.32544770 |
| 101 | Sclerocornea (HP:0000647) | 2.29153014 |
| 102 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.27927610 |
| 103 | Genital tract atresia (HP:0001827) | 2.26911633 |
| 104 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.26817785 |
| 105 | Glomerulonephritis (HP:0000099) | 2.26395617 |
| 106 | Congenital hepatic fibrosis (HP:0002612) | 2.26284694 |
| 107 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.26172804 |
| 108 | Abnormality of alanine metabolism (HP:0010916) | 2.26172804 |
| 109 | Hyperalaninemia (HP:0003348) | 2.26172804 |
| 110 | Abnormal gallbladder morphology (HP:0012437) | 2.23598207 |
| 111 | Abnormal drinking behavior (HP:0030082) | 2.21968999 |
| 112 | Polydipsia (HP:0001959) | 2.21968999 |
| 113 | Pancreatitis (HP:0001733) | 2.21281746 |
| 114 | Rickets (HP:0002748) | 2.21174779 |
| 115 | Mitral stenosis (HP:0001718) | 2.20590553 |
| 116 | Abnormality of urine glucose concentration (HP:0011016) | 2.20480380 |
| 117 | Glycosuria (HP:0003076) | 2.20480380 |
| 118 | Cholelithiasis (HP:0001081) | 2.19967782 |
| 119 | Polyphagia (HP:0002591) | 2.19711029 |
| 120 | Tubular atrophy (HP:0000092) | 2.18946244 |
| 121 | Vaginal atresia (HP:0000148) | 2.18110462 |
| 122 | Confusion (HP:0001289) | 2.16818889 |
| 123 | Poor coordination (HP:0002370) | 2.15114369 |
| 124 | Cholecystitis (HP:0001082) | 2.13303556 |
| 125 | Abnormal gallbladder physiology (HP:0012438) | 2.13303556 |
| 126 | Broad-based gait (HP:0002136) | 2.11626832 |
| 127 | Lissencephaly (HP:0001339) | 2.10878577 |
| 128 | Esophageal varix (HP:0002040) | 2.09757490 |
| 129 | Sensorimotor neuropathy (HP:0007141) | 2.08614902 |
| 130 | Late onset (HP:0003584) | 2.08306097 |
| 131 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.07855506 |
| 132 | Thrombophlebitis (HP:0004418) | 2.07310803 |
| 133 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.07197061 |
| 134 | Menorrhagia (HP:0000132) | 2.06693079 |
| 135 | Anencephaly (HP:0002323) | 2.06634343 |
| 136 | Gaze-evoked nystagmus (HP:0000640) | 2.05394645 |
| 137 | Gingival bleeding (HP:0000225) | 2.04853512 |
| 138 | Focal seizures (HP:0007359) | 2.03840021 |
| 139 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.02757266 |
| 140 | Pachygyria (HP:0001302) | 2.00609784 |
| 141 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99448307 |
| 142 | Male pseudohermaphroditism (HP:0000037) | 1.99122435 |
| 143 | Hypophosphatemic rickets (HP:0004912) | 1.99067625 |
| 144 | Keratoconus (HP:0000563) | 1.97316682 |
| 145 | Increased corneal curvature (HP:0100692) | 1.97316682 |
| 146 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.96284124 |
| 147 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.96028470 |
| 148 | Brushfield spots (HP:0001088) | 1.95748449 |
| 149 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.95354620 |
| 150 | Postaxial foot polydactyly (HP:0001830) | 1.93508442 |
| 151 | Poikilocytosis (HP:0004447) | 1.92818970 |
| 152 | Chorioretinal atrophy (HP:0000533) | 1.92532135 |
| 153 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.91007714 |
| 154 | Absent/shortened dynein arms (HP:0200106) | 1.91007714 |
| 155 | Opisthotonus (HP:0002179) | 1.90356241 |
| 156 | Decreased circulating renin level (HP:0003351) | 1.90346113 |
| 157 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.90234586 |
| 158 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.90209505 |
| 159 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.90209505 |
| 160 | Focal motor seizures (HP:0011153) | 1.89559852 |
| 161 | Nausea (HP:0002018) | 1.89444153 |
| 162 | Abnormality of vitamin metabolism (HP:0100508) | 1.89399993 |
| 163 | Hemorrhage of the eye (HP:0011885) | 1.89379746 |
| 164 | Abnormality of the labia minora (HP:0012880) | 1.89067197 |
| 165 | Abnormal cartilage morphology (HP:0002763) | 1.88984954 |
| 166 | Polyuria (HP:0000103) | 1.88833142 |
| 167 | Nephrolithiasis (HP:0000787) | 1.88593279 |
| 168 | Retinitis pigmentosa (HP:0000510) | 1.85790865 |
| 169 | Dyskinesia (HP:0100660) | 1.84686182 |
| 170 | Asplenia (HP:0001746) | 1.82351012 |
| 171 | Status epilepticus (HP:0002133) | 1.80984413 |
| 172 | Thyroid-stimulating hormone excess (HP:0002925) | 1.80763478 |
| 173 | Agitation (HP:0000713) | 1.80242159 |
| 174 | Generalized hypopigmentation of hair (HP:0011358) | 1.79420203 |
| 175 | Specific learning disability (HP:0001328) | 1.79268550 |
| 176 | Acute encephalopathy (HP:0006846) | 1.78411376 |
| 177 | Rib fusion (HP:0000902) | 1.78030897 |
| 178 | Congenital sensorineural hearing impairment (HP:0008527) | 1.77534498 |
| 179 | Inability to walk (HP:0002540) | 1.76787889 |
| 180 | Drooling (HP:0002307) | 1.76758760 |
| 181 | Dialeptic seizures (HP:0011146) | 1.75773077 |
| 182 | Acute necrotizing encephalopathy (HP:0006965) | 1.75026812 |
| 183 | Postaxial hand polydactyly (HP:0001162) | 1.74809917 |
| 184 | Epileptic encephalopathy (HP:0200134) | 1.71010309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.57877209 |
| 2 | FGFR4 | 4.28803333 |
| 3 | SIK1 | 3.93730391 |
| 4 | ERN1 | 3.93473235 |
| 5 | BMPR1B | 3.24614325 |
| 6 | INSRR | 2.76641664 |
| 7 | WNK3 | 2.56590263 |
| 8 | WNK4 | 2.46007047 |
| 9 | TAOK3 | 2.36986217 |
| 10 | ADRBK2 | 2.35345468 |
| 11 | ACVR1B | 2.25412585 |
| 12 | MST1R | 2.22105414 |
| 13 | PKN2 | 2.22094384 |
| 14 | ERBB4 | 2.20447780 |
| 15 | MAP4K2 | 2.19279726 |
| 16 | CASK | 2.14271514 |
| 17 | MAPK13 | 2.11413856 |
| 18 | MAP3K4 | 2.06449704 |
| 19 | OXSR1 | 2.02468615 |
| 20 | NUAK1 | 1.96952552 |
| 21 | MAP2K4 | 1.95896569 |
| 22 | TRIB3 | 1.83458235 |
| 23 | MAPK11 | 1.78055299 |
| 24 | FLT3 | 1.77308073 |
| 25 | DYRK2 | 1.62650039 |
| 26 | PIK3CG | 1.62229156 |
| 27 | NTRK3 | 1.62167366 |
| 28 | ZAK | 1.59937470 |
| 29 | PTK6 | 1.55619544 |
| 30 | MAP2K7 | 1.54456753 |
| 31 | TXK | 1.53605128 |
| 32 | MARK1 | 1.52136821 |
| 33 | TYK2 | 1.51572257 |
| 34 | DAPK2 | 1.49172246 |
| 35 | TNIK | 1.46163611 |
| 36 | STK38L | 1.44473246 |
| 37 | ABL2 | 1.43357210 |
| 38 | STK16 | 1.39964350 |
| 39 | LATS1 | 1.36267661 |
| 40 | KDR | 1.34957329 |
| 41 | GRK6 | 1.34766312 |
| 42 | PIK3CA | 1.34060602 |
| 43 | NTRK2 | 1.31509817 |
| 44 | CDK19 | 1.28183166 |
| 45 | NEK9 | 1.27968622 |
| 46 | PINK1 | 1.21945577 |
| 47 | CAMKK2 | 1.16744989 |
| 48 | MAP2K3 | 1.12686111 |
| 49 | TIE1 | 1.12271280 |
| 50 | ADRBK1 | 1.11644917 |
| 51 | JAK2 | 1.10638653 |
| 52 | MAP3K3 | 1.10261073 |
| 53 | PRKAA2 | 1.06869592 |
| 54 | FRK | 1.05791927 |
| 55 | MAP3K7 | 1.05559896 |
| 56 | SIK2 | 1.03751117 |
| 57 | TLK1 | 1.01611856 |
| 58 | MET | 0.96786774 |
| 59 | BCR | 0.96579662 |
| 60 | EPHB1 | 0.96255452 |
| 61 | FGFR2 | 0.95930369 |
| 62 | MAP3K11 | 0.94697231 |
| 63 | STK11 | 0.92708904 |
| 64 | CSNK1G2 | 0.86130531 |
| 65 | TGFBR2 | 0.85969833 |
| 66 | SGK223 | 0.85094962 |
| 67 | SGK494 | 0.85094962 |
| 68 | MAP3K10 | 0.84427717 |
| 69 | PRKCE | 0.84163291 |
| 70 | PRKCZ | 0.83712413 |
| 71 | TBK1 | 0.82427308 |
| 72 | PLK2 | 0.80843411 |
| 73 | MAPK4 | 0.80814489 |
| 74 | ERBB2 | 0.80687583 |
| 75 | PTK2 | 0.80487624 |
| 76 | GSK3A | 0.79171502 |
| 77 | DYRK1B | 0.77239097 |
| 78 | PRKACG | 0.76243468 |
| 79 | MAP3K14 | 0.75909230 |
| 80 | EPHB2 | 0.75281383 |
| 81 | JAK1 | 0.75137562 |
| 82 | NEK1 | 0.74979534 |
| 83 | SGK3 | 0.74822198 |
| 84 | MAPK12 | 0.74241309 |
| 85 | CSNK1A1L | 0.73117176 |
| 86 | AKT3 | 0.73004688 |
| 87 | MKNK2 | 0.71317262 |
| 88 | PRKAA1 | 0.69480243 |
| 89 | TGFBR1 | 0.68868724 |
| 90 | TEC | 0.67354688 |
| 91 | PRKACA | 0.66552165 |
| 92 | CAMK1 | 0.66098936 |
| 93 | MAPK15 | 0.66045047 |
| 94 | PDK4 | 0.65764390 |
| 95 | PDK3 | 0.65764390 |
| 96 | OBSCN | 0.64336089 |
| 97 | STK3 | 0.63286780 |
| 98 | CDK6 | 0.63211697 |
| 99 | STK39 | 0.62696367 |
| 100 | CSK | 0.62304870 |
| 101 | SGK2 | 0.61668331 |
| 102 | RIPK1 | 0.61556383 |
| 103 | PDPK1 | 0.60475834 |
| 104 | CSNK1G3 | 0.60341326 |
| 105 | MAP2K6 | 0.59398416 |
| 106 | TRIM28 | 0.58679208 |
| 107 | DYRK1A | 0.58282551 |
| 108 | PHKG2 | 0.58169286 |
| 109 | PHKG1 | 0.58169286 |
| 110 | TAF1 | 0.57451571 |
| 111 | TNK2 | 0.57329802 |
| 112 | MINK1 | 0.57174273 |
| 113 | GRK7 | 0.56771100 |
| 114 | DYRK3 | 0.55659595 |
| 115 | CAMK2G | 0.54768671 |
| 116 | PKN1 | 0.54386121 |
| 117 | CAMK2A | 0.52793981 |
| 118 | SGK1 | 0.50232405 |
| 119 | CSNK1A1 | 0.50137640 |
| 120 | EPHA3 | 0.49979314 |
| 121 | BRSK2 | 0.48097352 |
| 122 | TAOK2 | 0.48018768 |
| 123 | WNK1 | 0.47365635 |
| 124 | KIT | 0.46195785 |
| 125 | PRKG1 | 0.44248370 |
| 126 | PRKCQ | 0.43709343 |
| 127 | MAP2K1 | 0.43471883 |
| 128 | GRK1 | 0.43219532 |
| 129 | ERBB3 | 0.42962172 |
| 130 | MUSK | 0.42905146 |
| 131 | PBK | 0.41981380 |
| 132 | CSNK1D | 0.41147629 |
| 133 | CAMK1D | 0.40762554 |
| 134 | EPHA4 | 0.40012174 |
| 135 | GRK5 | 0.39858399 |
| 136 | PDK1 | 0.39845453 |
| 137 | CAMKK1 | 0.39792261 |
| 138 | CDK5 | 0.37762455 |
| 139 | PRKCG | 0.37031978 |
| 140 | IGF1R | 0.36822271 |
| 141 | MAPK7 | 0.35954026 |
| 142 | CSF1R | 0.35034759 |
| 143 | PAK3 | 0.34851715 |
| 144 | CSNK1G1 | 0.34610831 |
| 145 | RPS6KA5 | 0.33124614 |
| 146 | MAP3K5 | 0.33058777 |
| 147 | IRAK3 | 0.32804241 |
| 148 | RET | 0.32135421 |
| 149 | IKBKE | 0.31761766 |
| 150 | PDK2 | 0.31648551 |
| 151 | RPS6KA3 | 0.31301692 |
| 152 | STK38 | 0.29298022 |
| 153 | MTOR | 0.28564974 |
| 154 | FGFR3 | 0.28492930 |
| 155 | CDK4 | 0.28333958 |
| 156 | CAMK4 | 0.27635954 |
| 157 | PRKCA | 0.27294604 |
| 158 | MAP3K2 | 0.26983056 |
| 159 | MAP2K2 | 0.26380005 |
| 160 | EGFR | 0.26327325 |
| 161 | MAP3K6 | 0.26219425 |
| 162 | MAP3K13 | 0.26006064 |
| 163 | LRRK2 | 0.23883793 |
| 164 | MAP3K1 | 0.23672552 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.13071213 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.47754985 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40832923 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.30027029 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.95762869 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.82020072 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67985566 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.65068391 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.60802109 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.59247117 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56604850 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.54832375 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.35866690 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.29617561 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.13370224 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.13128640 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.07527985 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.98227136 |
| 19 | Nicotine addiction_Homo sapiens_hsa05033 | 1.97226075 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.86608756 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.86322538 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85642546 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.84623420 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83928071 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.78738137 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76904892 |
| 27 | Phototransduction_Homo sapiens_hsa04744 | 1.76234201 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.73978440 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.69206841 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.59344212 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.59008061 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.55820921 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.55358035 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54531292 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.53672345 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.51385082 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.50346010 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.50147661 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.44081807 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.37762113 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.36257995 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.33858042 |
| 43 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.33028760 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.28826495 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.27496417 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.25254496 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24381566 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24209485 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.24047369 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22461475 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.21016443 |
| 52 | Morphine addiction_Homo sapiens_hsa05032 | 1.19927545 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17908605 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.15659000 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.12581339 |
| 56 | GABAergic synapse_Homo sapiens_hsa04727 | 1.10808787 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.08876870 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 1.07170605 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04527939 |
| 60 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.03476845 |
| 61 | Taste transduction_Homo sapiens_hsa04742 | 1.01929289 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97770144 |
| 63 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96732888 |
| 64 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.95283120 |
| 65 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94791851 |
| 66 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.90954327 |
| 67 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.90009868 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.89488048 |
| 69 | Lysine degradation_Homo sapiens_hsa00310 | 0.88560840 |
| 70 | Protein export_Homo sapiens_hsa03060 | 0.88441060 |
| 71 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.88122071 |
| 72 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.86934824 |
| 73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.86315619 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82924583 |
| 75 | Olfactory transduction_Homo sapiens_hsa04740 | 0.81835791 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79952919 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79789885 |
| 78 | Insulin secretion_Homo sapiens_hsa04911 | 0.79205955 |
| 79 | Circadian entrainment_Homo sapiens_hsa04713 | 0.76643098 |
| 80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.73710013 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71711222 |
| 82 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.70980468 |
| 83 | Parkinsons disease_Homo sapiens_hsa05012 | 0.70437699 |
| 84 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.69632762 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62250529 |
| 86 | Homologous recombination_Homo sapiens_hsa03440 | 0.57054493 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48591671 |
| 88 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.47134731 |
| 89 | Salivary secretion_Homo sapiens_hsa04970 | 0.45113229 |
| 90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40730056 |
| 91 | Alzheimers disease_Homo sapiens_hsa05010 | 0.39114639 |
| 92 | Huntingtons disease_Homo sapiens_hsa05016 | 0.38741162 |
| 93 | Basal transcription factors_Homo sapiens_hsa03022 | 0.36840964 |
| 94 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.36439107 |
| 95 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.35395599 |
| 96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35327735 |
| 97 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34662567 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34331837 |
| 99 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.32843639 |
| 100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32024950 |
| 101 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.31667731 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30782683 |
| 103 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.30444933 |
| 104 | Cocaine addiction_Homo sapiens_hsa05030 | 0.29650341 |
| 105 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.28189651 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25914720 |
| 107 | RNA degradation_Homo sapiens_hsa03018 | 0.25875298 |
| 108 | Renin secretion_Homo sapiens_hsa04924 | 0.23588325 |
| 109 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.22025634 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.20761067 |
| 111 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19794672 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.19642297 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17763343 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10943007 |
| 115 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07368758 |
| 116 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.00549043 |
| 117 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00360818 |
| 118 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2029363 |
| 119 | Lysosome_Homo sapiens_hsa04142 | -0.1930080 |
| 120 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1861179 |
| 121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1841221 |
| 122 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1776343 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | -0.1750040 |
| 124 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1649027 |
| 125 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1631153 |
| 126 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1630957 |
| 127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1604686 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1354430 |
| 129 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1323514 |
| 130 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1312129 |
| 131 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1064277 |
| 132 | Mineral absorption_Homo sapiens_hsa04978 | -0.1052741 |
| 133 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1044716 |
| 134 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1017722 |
| 135 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0882933 |
| 136 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0463992 |
| 137 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0260737 |

